Contact

You can contact the executive board here.

Phone:
+49 (0) 61 95 - 987 48 30

We look forward to your call!

UnternehmensBörse Grönig & Kollegen AG
Schöne Aussicht 18
65779 Kelkheim-Fischbach (Taunus)

e-mail: info@unternehmensboerse-abos.de

Übersicht mit allen aktuellen Verkaufsangeboten

Ein Unternehmensverkauf erfordert zielgerichtetes und professionelles Handeln. Wir suchen für Sie den passenden Käufer und führen Sie durch den Verkaufsprozess bis zum erfolgreichen Unternehmensverkauf.

Unternehmensverkauf
Unternehmensverkauf

Sie möchten ein Unternehmen kaufen oder Anteile erwerben? Wir helfen Ihnen dabei, das gewünschte Unternehmen zu finden, unterstützen Sie bei der Analyse und führen die Verhandlungen bis zum erfolgreichen Vertragsabschluss.

Unternehmenskauf
Unternehmenskauf

Wir finden für Sie finanzstarke Partner, bringen Kapitalgeber und Firmeninhaber zusammen und prüfen den Markt auf Übereinstimmungen.

Das Ergebnis: eine Auswahl an individuellen Investitionsmöglichkeiten oder Investoren, die perfekt zu Ihnen passen.

Unternehmensbeteiligungen
Unternehmensbeteiligungen

Die Unternehmensbörse Grönig & Kollegen ist Ihr Marktplatz für geprüfte Unternehmensangebote und -gesuche. Vertrauen Sie auf unsere qualitätsgeprüften Unternehmen und Investoren.

Marktplatz
Marktplatz

Medical technology / services for medicine in hospitals and clinics

Customer Id
61006
Corporate form
GmbH
Industry
Medical technology / services for medicine in hospitals and clinics
Location
Southern Germany
Business operations

Highly specialised service provider for hospitals and clinics with a focus on the process chain and optimisation. The emphasis is on equipping the surgical area with materials, including logistics. In addition, personnel services (supply of temporary personnel and placement of medical professionals). To complete the range of services, consultancy services (advice and support to clinics in the area of ​​implementation for process optimisation, and a training department) were on offer. and an academy (further education and training for specialist staff in medical and non-medical areas) was added. 

History

Founded in 1998 as a sole proprietorship, after several expansions of the range of services, each of which was handled in specially set-up companies, an umbrella company was founded in 2019 which gathered 4 subsidiaries together. 

Wealth

100% of the company shares of the entire group of companies (holding company plus 4 subsidiaries)

Development potential

The company has achieved an excellent competitive position in the market, thanks to its wide range of industry and customer-specific products and services, which are very well tailored to customers' needs. Therefore, if the pandemic is contained quickly and sustainably, strongly disproportionate growth can be expected among contractually connected customers due to the immense need to catch up across the whole spectrum of products and services. Further major growth potential can be seen in the acquisition of additional customers in the area of ​​privately run or economically healthier clinics and clinic groups. 

Staff

The company currently has a total of 72 permanent employees. Average age 39, average length of employment just under 4 years. Above-average level of qualifications. Flat hierarchy, short decision-making paths and a well-functioning 2ndlevel

Customers

70 - 80% of sales with over 20 top customers, most of whom have been connected for >10 years (90% public institutions such as clinics and hospitals). The remaining sales are divided between a further 40 customers, with 25 customers accounting for sales of an average of €100,000. As a rule, new customer acquisition initially takes place via detailed process analyses and advice based on this 

Sales reason

Age-related company succession.

Company figures

The company's economic situation in the last few years before the outbreak of the pandemic can be regarded as stable and shows a clear, sustainable growth curve. There were significant effects on sales and earnings related to Covid-19, but nonetheless continued positive earnings in 2020 and 2021.
The overall performance in 2019 was €19.4 million, the EBIT was €1.02 million. 

Sales conditions

The intention is to sell 100% of the shares in a share deal. Value indication for 100% of the company shares (holding company plus 4 subsidiaries) amounting to €6.95 million. 

Sales category
more than 10 Mio.
Confidential brief description: Confidential abstract: All information is based on data provided by the seller and is compiled to the best of our knowledge. All statements without guarantee!